Feb 27, 2025 / 09:30AM GMT
Richard Fairman - CVS Group PLC - Chief Executive Officer, Executive Director
Welcome to this presentation of CVS Group's interim financial results for the six-month period ended December 31, 2024. I am Richard Fairman, CEO; and I'm joined by Robin Alfonso, CFO; and Paul Higgs, Chief Veterinary Officer. I am pleased to report that the group has delivered further growth in both revenue and adjusted EBITDA in the first half. Proactively managing the current weaker consumer demand for veterinary care in the UK, whilst focusing on increasing CVS footprint and growth in the Australian veterinary market.
We delivered revenue of GBP341.8 million pounds in the first half, and this represents growth of 6.6% over the equivalent period in the previous financial year. Life alike sales decline 1.1% in the period, impacted by softer market conditions in the UK, most notably in our online retail and laboratory businesses.
Performance across our core veterinary practices division was flat, although we expect to deliver year on year growth in this division and across the group in the second half of the
Half Year 2025 CVS Group PLC Earnings Call Transcript
Feb 27, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers